Trademark Overview
On Friday, November 14, 2025, a trademark application was filed for CODIS with the United States Patent and Trademark Office. The USPTO has given the CODIS trademark a serial number of 99496902. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 21, 2026. This trademark is owned by Particle Dynamics Holdings, Inc. The CODIS trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical research and development; contract development services for pharmaceuticals; Pharmaceutical research and development in the nature of pharmaceutical product design and optimization; Pharmaceutical research and development in the nature of analytical testing of pharmaceuticals; Pharmaceutical research and development in the nature of stability testing; Pharmaceutical research and development in the nature of method development and validation; Pharmaceutical research and development in the nature of technology transfer in the field of pharmaceuticals; consulting services in the field of drug development and manufacturing
Contract pharmaceutical manufacturing services in the field of pharmaceuticals; custom synthesis of active pharmaceutical ingredients (APIs); formulation of pharmaceutical preparations for others; Contract pharmaceutical manufacturing services in the nature of pharmaceutical spray drying services; Contract pharmaceutical manufacturing services in the nature of solvent spray drying services; Contract pharmaceutical manufacturing services in the nature of pharmaceutical tableting, encapsulation, and blending services; Contract pharmaceutical manufacturing services in the nature of packaging services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of labeling services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of processing of pharmaceutical intermediates; scale-up and commercial manufacturing of pharmaceutical products for others; consulting services in the field of manufacturing
Dietary and nutritional supplements; active pharmaceutical ingredients (APIs), namely, Sevelamer Carbonate and Sevelamer Hydrochloride; drug delivery systems in the form of amorphous solid dispersions that facilitate the delivery of pharmaceutical preparations; spray-dried pharmaceutical products for treatment of hyperphosphatemia
Magnesium carbonate; Particulate precursor components in the nature of chemical additives for use in the manufacture of pharmaceutical tablets and nutritional and dietary supplements; chemicals sold in bulk for use in the manufacturing, processing and packing of nutritional supplements, vitamins, and pharmaceutical products and preparations; chemical encased in a matrix which is sold in bulk for manufacturing, processing or repacking of chemicals; Chemical tastemasking additives, stability and flavor enhancers, for use in the manufacture of pharmaceuticals, namely, antihistamines, anti-nausea agents, neonatal agents, osteoporetic, nutraceuticals, and pharmaceuticals, namely, hormones, anti-infectives, and fertility agents; Excipients for use in the manufacture of pharmaceuticals
